Tidal Investments LLC Has $14.09 Million Stake in Tilray Inc (NASDAQ:TLRY)

Tidal Investments LLC grew its holdings in shares of Tilray Inc (NASDAQ:TLRY - Free Report) by 9.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,595,264 shares of the company's stock after purchasing an additional 889,086 shares during the period. Tidal Investments LLC owned approximately 1.13% of Tilray worth $14,092,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Newman Dignan & Sheerar Inc. boosted its stake in Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after buying an additional 10,000 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in Tilray by 55.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 31,875 shares of the company's stock valued at $42,000 after buying an additional 11,325 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Tilray by 92.1% during the fourth quarter. NewEdge Advisors LLC now owns 27,406 shares of the company's stock valued at $36,000 after purchasing an additional 13,136 shares during the last quarter. TD Waterhouse Canada Inc. lifted its holdings in shares of Tilray by 59.4% during the fourth quarter. TD Waterhouse Canada Inc. now owns 37,009 shares of the company's stock valued at $49,000 after purchasing an additional 13,786 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC boosted its position in shares of Tilray by 68.0% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 35,121 shares of the company's stock valued at $47,000 after purchasing an additional 14,221 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Stock Down 0.0%

NASDAQ:TLRY traded down $0.00 on Tuesday, hitting $0.45. 18,924,983 shares of the company's stock traded hands, compared to its average volume of 28,140,591. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. Tilray Inc has a 1 year low of $0.41 and a 1 year high of $2.15. The firm has a 50-day moving average price of $0.53 and a 200-day moving average price of $0.94. The company has a market cap of $455.84 million, a PE ratio of -1.51 and a beta of 1.95.

Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The company had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. Equities analysts anticipate that Tilray Inc will post -0.2 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Roth Capital reiterated a "neutral" rating on shares of Tilray in a research report on Monday, April 14th. Piper Sandler decreased their price target on Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research report on Wednesday, April 9th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.